Vaihdevuodet, näytönastekatsausten kirjallisuusviitteet

Kirjallisuutta

1. Anderson GL, Limacher M, Assaf AR, ym. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291(14):1701-12 «PMID: 15082697»PubMed
2. Banks E, Beral V, Reeves G, ym. Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women. JAMA 2004;291(18):2212-20 «PMID: 15138243»PubMed
3. Bea JW, Zhao Q, Cauley JA, ym. Effect of hormone therapy on lean body mass, falls, and fractures: 6-year results from the Women's Health Initiative hormone trials. Menopause 2011;18(1):44-52 «PMID: 20689466»PubMed
4. Biehl C, Plotsker O, Mirkin S. A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopause. Menopause 2019;26(4):431-453 «PMID: 30363010»PubMed
5. Biglia N, Bounous VE, De Seta F, ym. Non-hormonal strategies for managing menopausal symptoms in cancer survivors: an update. Ecancermedicalscience 2019;13:909 «PMID: 31123492»PubMed
6. Black DR, Minkin MJ, Graham S, ym. Effects of combined 17β-estradiol and progesterone on weight and blood pressure in postmenopausal women of the REPLENISH trial. Menopause 2020;28(1):32-39 «PMID: 32932401»PubMed
7. Boardman HM, Hartley L, Eisinga A, ym. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev 2015;2015(3):CD002229 «PMID: 25754617»PubMed
8. Brusselaers N, Tamimi RM, Konings P, ym. Different menopausal hormone regimens and risk of breast cancer. Ann Oncol 2018;29(8):1771-1776 «PMID: 29917061»PubMed
9. Caan B, LaCroix AZ, Joffe H, ym. Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial. Menopause 2015;22(6):607-15 «PMID: 25405571»PubMed
10. Canonico M, Carcaillon L, Plu-Bureau G, ym. Postmenopausal Hormone Therapy and Risk of Stroke: Impact of the Route of Estrogen Administration and Type of Progestogen. Stroke 2016;47(7):1734-41 «PMID: 27256671»PubMed
11. Canonico M, Plu-Bureau G, Lowe GD, ym. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ 2008;336(7655):1227-31 «PMID: 18495631»PubMed
12. Cauley JA, Robbins J, Chen Z, ym. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA 2003;290(13):1729-38 «PMID: 14519707»PubMed
13. Chen YY, Su TH, Lau HH. Estrogen for the prevention of recurrent urinary tract infections in postmenopausal women: a meta-analysis of randomized controlled trials. Int Urogynecol J 2021;32(1):17-25 «PMID: 32564121»PubMed
14. Chlebowski RT, Anderson GL, Aragaki AK, ym. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials. JAMA 2020;324(4):369-380 «PMID: 32721007»PubMed
15. Christmas MM, Iyer S, Daisy C, ym. Menopause hormone therapy and urinary symptoms: a systematic review. Menopause 2023;30(6):672-685 «PMID: 37192832»PubMed
16. Cold S, Cold F, Jensen MB, ym. Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study. J Natl Cancer Inst 2022;114(10):1347-1354 «PMID: 35854422»PubMed
17. Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. Lancet 2019;394(10204):1159-1168 «PMID: 31474332»PubMed
18. Constantine GD, Graham S, Lapane K, ym. Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence review. Menopause 2019;26(7):800-807 «PMID: 30889085»PubMed
19. Coronado PJ, Gómez A, Iglesias E, ym. Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis. Menopause 2024;31(3):234-242 «PMID: 38385734»PubMed
20. Dueñas-Garcia OF, Sullivan G, Hall CD, ym. Pharmacological Agents to Decrease New Episodes of Recurrent Lower Urinary Tract Infections in Postmenopausal Women. A Systematic Review. Female Pelvic Med Reconstr Surg 2016;22(2):63-9 «PMID: 26825411»PubMed
21. Fahlén M, Fornander T, Johansson H, ym. Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial. Eur J Cancer 2013;49(1):52-9 «PMID: 22892060»PubMed
22. Finkelstein JS, Lee H, Karlamangla A, ym. Antimullerian Hormone and Impending Menopause in Late Reproductive Age: The Study of Women's Health Across the Nation. J Clin Endocrinol Metab 2020;105(4):e1862-71 «PMID: 31965189»PubMed
23. Fiol G, Lete I, Nieto L, ym. Associations between Menopausal Hormone Therapy and Colorectal, Lung, or Melanoma Cancer Recurrence and Mortality: A Narrative Review. J Clin Med 2023;12(16): «PMID: 37629305»PubMed
24. Franco OH, Chowdhury R, Troup J, ym. Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis. JAMA 2016;315(23):2554-63 «PMID: 27327802»PubMed
25. Freeman EW, Sammel MD, Lin H, ym. Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab 2012;97(5):1673-80 «PMID: 22378815»PubMed
26. Gaudard AM, Silva de Souza S, Puga ME, ym. Bioidentical hormones for women with vasomotor symptoms. Cochrane Database Syst Rev 2016;2016(8):CD010407 «PMID: 27479272»PubMed
27. Heikkinen J, Vaheri R, Timonen U. A 10-year follow-up of postmenopausal women on long-term continuous combined hormone replacement therapy: Update of safety and quality-of-life findings. J Br Menopause Soc 2006;12(3):115-25 «PMID: 16953985»PubMed
28. Heikkinen JE, Vaheri RT, Ahomäki SM, ym. Optimizing continuous-combined hormone replacement therapy for postmenopausal women: a comparison of six different treatment regimens. Am J Obstet Gynecol 2000;182(3):560-7 «PMID: 10739508»PubMed
29. Hirschberg AL, Sánchez-Rovira P, Presa-Lorite J, ym. Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial. Menopause 2020;27(5):526-534 «PMID: 32049923»PubMed
30. Holmberg L, Anderson H, HABITS steering and data monitoring committees. HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped. Lancet 2004;363(9407):453-5 «PMID: 14962527»PubMed
31. Holmberg L, Iversen OE, Rudenstam CM, ym. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors. J Natl Cancer Inst 2008;100(7):475-82 «PMID: 18364505»PubMed
32. Imtiaz B, Taipale H, Tanskanen A, ym. Risk of Alzheimer's disease among users of postmenopausal hormone therapy: A nationwide case-control study. Maturitas 2017;98:7-13 «PMID: 28274328»PubMed
33. Islam RM, Bell RJ, Green S, ym. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol 2019;7(10):754-766 «PMID: 31353194»PubMed
34. Jang YC, Leung CY, Huang HL. Comparison of Severity of Genitourinary Syndrome of Menopause Symptoms After Carbon Dioxide Laser vs Vaginal Estrogen Therapy: A Systematic Review and Meta-analysis. JAMA Netw Open 2022;5(9):e2232563 «PMID: 36129710»PubMed
35. Johnson KA, Martin N, Nappi RE, ym. Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT. J Clin Endocrinol Metab 2023;108(8):1981-1997 «PMID: 36734148»PubMed
36. Kenemans P, Bundred NJ, Foidart JM, ym. Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet Oncol 2009;10(2):135-46 «PMID: 19167925»PubMed
37. Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database Syst Rev 2012;2012(9):CD007244 «PMID: 22972105»PubMed
38. Lederman S, Ottery FD, Cano A, ym. Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study. Lancet 2023;401(10382):1091-1102 «PMID: 36924778»PubMed
39. Lethaby A, Ayeleke RO, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2016;2016(8):CD001500 «PMID: 27577677»PubMed
40. Lethaby A, Marjoribanks J, Kronenberg F, ym. Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst Rev 2013;2013(12):CD001395 «PMID: 24323914»PubMed
41. Lyytinen H, Pukkala E, Ylikorkala O. Breast cancer risk in postmenopausal women using estradiol-progestogen therapy. Obstet Gynecol 2009;113(1):65-73 «PMID: 19104361»PubMed
42. Løkkegaard E, Nielsen LH, Keiding N. Risk of Stroke With Various Types of Menopausal Hormone Therapies: A National Cohort Study. Stroke 2017;48(8):2266-2269 «PMID: 28626058»PubMed
43. Maclennan AH, Broadbent JL, Lester S, ym. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev 2004;2004(4):CD002978 «PMID: 15495039»PubMed
44. McVicker L, Labeit AM, Coupland CAC, ym. Vaginal Estrogen Therapy Use and Survival in Females With Breast Cancer. JAMA Oncol 2024;10(1):103-108 «PMID: 37917089»PubMed
45. Meziou N, Scholfield C, Taylor CA, ym. Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update. Menopause 2023;30(6):659-671 «PMID: 37159867»PubMed
46. Mikkola TS, Savolainen-Peltonen H, Tuomikoski P, ym. Lower Death Risk for Vascular Dementia Than for Alzheimer's Disease With Postmenopausal Hormone Therapy Users. J Clin Endocrinol Metab 2017;102(3):870-877 «PMID: 27906568»PubMed
47. Mikkola TS, Savolainen-Peltonen H, Tuomikoski P, ym. Reduced risk of breast cancer mortality in women using postmenopausal hormone therapy: a Finnish nationwide comparative study. Menopause 2016;23(11):1199-1203 «PMID: 27465718»PubMed
48. Mikkola TS, Tuomikoski P, Lyytinen H, ym. Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality. Menopause 2015;22(9):976-83 «PMID: 25803671»PubMed
49. Mohammed K, Abu Dabrh AM, Benkhadra K, ym. Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab 2015;100(11):4012-20 «PMID: 26544651»PubMed
50. Monda V, Salerno M, Fiorenzo M, ym. Role of Sex Hormones in the Control of Vegetative and Metabolic Functions of Middle-Aged Women. Front Physiol 2017;8:773 «PMID: 29046646»PubMed
51. Mosekilde L, Beck-Nielsen H, Sørensen OH, ym. Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women - results of the Danish Osteoporosis Prevention Study. Maturitas 2000;36(3):181-93 «PMID: 11063900»PubMed
52. Nelson SM, Davis SR, Kalantaridou S, ym. Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review. Hum Reprod Update 2023;29(3):327-346 «PMID: 36651193»PubMed
53. Norman RJ, Flight IH, Rees MC. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. Cochrane Database Syst Rev 2000;(2):CD001018 «PMID: 10796730»PubMed
54. Nudy M, Chinchilli VM, Foy AJ. A systematic review and meta-regression analysis to examine the 'timing hypothesis' of hormone replacement therapy on mortality, coronary heart disease, and stroke. Int J Cardiol Heart Vasc 2019;22:123-131 «PMID: 30705938»PubMed
55. Oliver-Williams C, Glisic M, Shahzad S, ym. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review. Hum Reprod Update 2019;25(2):257-271 «PMID: 30508190»PubMed
56. Paoletti AM, Cagnacci A, Di Carlo C, ym. Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study. Gynecol Endocrinol 2015;31(5):384-7 «PMID: 25703254»PubMed
57. Perrotta C, Aznar M, Mejia R, ym. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev 2008;(2):CD005131 «PMID: 18425910»PubMed
58. Pourhadi N, Mørch LS, Holm EA, ym. Menopausal hormone therapy and dementia: nationwide, nested case-control study. BMJ 2023;381:e072770 «PMID: 37380194»PubMed
59. Rada G, Capurro D, Pantoja T, ym. Non-hormonal interventions for hot flushes in women with a history of breast cancer. Cochrane Database Syst Rev 2010;(9):CD004923 «PMID: 20824841»PubMed
60. Randell KM, Honkanen RJ, Kröger H, ym. Does hormone-replacement therapy prevent fractures in early postmenopausal women? J Bone Miner Res 2002;17(3):528-33 «PMID: 11874244»PubMed
61. Renoux C, Dell'aniello S, Garbe E, ym. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ 2010;340:c2519 «PMID: 20525678»PubMed
62. Rovinski D, Ramos RB, Fighera TM, ym. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis. Thromb Res 2018;168:83-95 «PMID: 29936403»PubMed
63. Santoro N, Allshouse A, Neal-Perry G, ym. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study. Menopause 2017;24(3):238-246 «PMID: 27779568»PubMed
64. Sarmento ACA, Costa APF, Lírio J, ym. Efficacy of Hormonal and Nonhormonal Approaches to Vaginal Atrophy and Sexual Dysfunctions in Postmenopausal Women: A Systematic Review. Rev Bras Ginecol Obstet 2022;44(10):986-994 «PMID: 36446564»PubMed
65. Savolainen-Peltonen H, Hautamäki H, Tuomikoski P, ym. Health-related quality of life in women with or without hot flashes: a randomized placebo-controlled trial with hormone therapy. Menopause 2014;21(7):732-9 «PMID: 24219882»PubMed
66. Savolainen-Peltonen H, Rahkola-Soisalo P, Hoti F, ym. Use of postmenopausal hormone therapy and risk of Alzheimer's disease in Finland: nationwide case-control study. BMJ 2019;364:l665 «PMID: 30842086»PubMed
67. Scheffers CS, Armstrong S, Cantineau AE, ym. Dehydroepiandrosterone for women in the peri- or postmenopausal phase. Cochrane Database Syst Rev 2015;1(1):CD011066 «PMID: 25879093»PubMed
68. Schierbeck LL, Rejnmark L, Tofteng CL, ym. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ 2012;345:e6409 «PMID: 23048011»PubMed
69. Shan D, Zou L, Liu X, ym. Efficacy and safety of gabapentin and pregabalin in patients with vasomotor symptoms: a systematic review and meta-analysis. Am J Obstet Gynecol 2020;222(6):564-579.e12 «PMID: 31870736»PubMed
70. Sintonen H, Johansson S, Ohinmaa A, ym. Measuring health-related quality of life in women on hormone replacement therapy. Expert Rev Pharmacoecon Outcomes Res 2003;3(3):351-61 «PMID: 19807382»PubMed
71. Taylor HS, Tal A, Pal L, ym. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS). JAMA Intern Med 2017;177(10):1471-1479 «PMID: 28846767»PubMed
72. Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases. BMJ 2020;371:m3873 «PMID: 33115755»PubMed
73. Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ 2019;364:k4810 «PMID: 30626577»PubMed
74. Vinogradova Y, Dening T, Hippisley-Cox J, ym. Use of menopausal hormone therapy and risk of dementia: nested case-control studies using QResearch and CPRD databases. BMJ 2021;374:n2182 «PMID: 34588168»PubMed
75. von Schoultz E, Rutqvist LE, Stockholm Breast Cancer Study Group. Menopausal hormone therapy after breast cancer: the Stockholm randomized trial. J Natl Cancer Inst 2005;97(7):533-5 «PMID: 15812079»PubMed
76. Welton AJ, Vickers MR, Kim J, ym. Health related quality of life after combined hormone replacement therapy: randomised controlled trial. BMJ 2008;337:a1190 «PMID: 18719013»PubMed
77. Ylikangas S, Sintonen H, Heikkinen J. Decade-long use of continuous combined hormone replacement therapy is associated with better health-related quality of life in postmenopausal women, as measured by the generic 15D instrument. J Br Menopause Soc 2005;11(4):145-51 «PMID: 16354458»PubMed
78. Yu X, Zhou S, Wang J, ym. Hormone replacement therapy and breast cancer survival: a systematic review and meta-analysis of observational studies. Breast Cancer 2017;24(5):643-657 «PMID: 28601917»PubMed
79. Zhang J, Wang X, Ren Z, ym. Impact of age and menopausal stage on serum anti-Müllerian hormone levels in middle-aged women. Climacteric 2021;24(6):618-623 «PMID: 34427163»PubMed
80. Zhu L, Jiang X, Sun Y, ym. Effect of hormone therapy on the risk of bone fractures: a systematic review and meta-analysis of randomized controlled trials. Menopause 2016;23(4):461-70 «PMID: 26529613»PubMed